Granisetron
CAS 109889-09-0
Overview
Granisetron injection is used to prevent nausea and vomiting that may occur after treatment with cancer medicines (chemotherapy or radiation), including high-dose cisplatin
Anant Labs manufacture and furnish high quality Granisetron impurities for global markets. Our Granisetron EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Technical Data
CAS109889-09-0
Mol. FormulaC18H24N4O
Mol. Weight312.417 g/mol
IUPAC1-methyl-N-[(1R,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide
SMILESCN1[C@@H]2CCC[C@H]1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
InChIInChI=1S/C18H24N4O/c1-21-13-6-5-7-14(21)11-12(10-13)19-18(23)17-15-8-3-4-9-16(15)22(2)20-17/h3-4,8-9,12-14H,5-7,10-11H2,1-2H3,(H,19,23)/t12?,13-,14+
InChI KeyMFWNKCLOYSRHCJ-AGUYFDCRSA-N
Note: We are upgrading our system, Cat No will change.
Synonyms
Granisetron (JAN/USAN/INN)RefChem:1086176granisetron109889-09-0SancusoSustolexo-GranisetronKevatrilBRL-43694Granisetronum
